Primary vs metastatic pulmonary adenocarcinoma: Toward a fuller understanding of truth

Chest

Volumn 137, Issue 1, 2010, Pages 3-4

  Zander, Dani S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; PROTEIN P53;

CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; COMPARATIVE STUDY; EDITORIAL; EVIDENCE BASED PRACTICE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; KIRSTEN SARCOMA ONCOVIRUS; LUNG ADENOCARCINOMA; LUNG METASTASIS; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; OBSERVER VARIATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIMARY TUMOR; PRIORITY JOURNAL; SCREENING TEST; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; TURNAROUND TIME; VIRUS ONCOGENE; X CHROMOSOME INACTIVATION;

EID: 74949114965     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1514     Document Type: Editorial

References (5)

1. Girard N, Deshpande C, Azzoli CG, et al. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to defi ne clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. Chest. 2010;137(1):46-52.
2. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70(4):606-612.
3. Shen KR, Meyers BF, Larner JM, Jones DR; American College of Chest Physicians. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):290S-305S.
4. Wang X, Wang M, MacLennan GT, et al. Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst. 2009;101(8):560-570.
5. Mercer RR, Lucas NC, Simmons AN, et al. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung. Exp Mol Pathol. 2009;86(1):1-9.